ArticleCancers2022

Regulation of a Novel Splice Variant of Early Growth Response 4 (EGR4-S) by HER+ Signalling and HSF1 in Breast Cancer.

Jeremy M Drake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.